The Natural History of Danon Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-30

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Danon disease (DD) is a rare, X-linked disorder associated with severe cardiomyopathy, and in many cases, skeletal myopathy, and cognitive impairment caused by mutations in the LAMP2 gene. There is still uncertainty regarding the natural history of DD because of its rarity.

This study aims to determine the natural history of DD through the collection and analysis of retrospective and prospective data. To achieve this, the investigators will perform surveys and obtain medical records from DD patients. The same cohort of patients will also be assessed by a multidisciplinary team with expertise in DD (cardiologist, neurologist, ophthalmologist, psychologist, geneticist) at the University of California, San Diego. All patients with DD are eligible, including those who underwent a heart transplant. Additionally, data and records from deceased patients will provide valuable retrospective data for this study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical, Molecular and Physiopathological Study of Cohen Syndrome and Cohen-like Syndromes

NCT01907555

Cohen Syndrome

COMPLETED

A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype

NCT01358370

Lysosomal Acid Lipase Deficiency Wolman Disease

COMPLETED

Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB

NCT02293408

MPS IIIB (Sanfilippo B Syndrome)

TERMINATED

Fabry's Disease and Pregnancy (PREFAB)

NCT02582294

Fabry's Disease Pregnancy

TERMINATED

Natural History of the Progression of X-Linked Retinitis Pigmentosa

NCT04926129

X-Linked Retinitis Pigmentosa

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study design will include:

1. Collection of information for all patients from:

* Survey of patient or caregiver (if the patient has deceased)
* Medical Charts
2. Collection of information from living patients assessed by the multidisciplinary team at the University of California, San Diego including:

* A complete medical history and physical examination
* Cardiac Testing (Electrocardiography; Echocardiography; Cardiac magnetic resonance imaging with gadolinium contrast agent-gadolinium contrast is optional-; Cardiopulmonary Test)
* Pulmonary function testing (PFT)
* Neuromuscular Assessment
* Cognitive Tests
* Vision exam including retinal evaluation
* Laboratory Tests
* Questionnaires on Quality of life
* Needle Skeletal muscle biopsy (only for patients over 18 years old)
* Abdominal Ultrasound for assessment of the liver structure

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Danon Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Danon Disease Patients

Patients with a confirmed diagnosis of Danon disease who are currently alive (including patients who may or may not have undergone heart transplantation).

No interventions assigned to this group

Deceased Danon Disease Patients

Patients with a confirmed diagnosis of Danon disease who are deceased (including patients who may or may not have undergone heart transplantation).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Living or deceased patients with a diagnosis of Danon disease(including patients who may or may not have undergone heart transplantation) based on a genetic test positive for the LAMP2 mutation